Literature DB >> 28165529

Molecular Biomarkers for the Evaluation of Colorectal Cancer.

Antonia R Sepulveda1, Stanley R Hamilton2, Carmen J Allegra3, Wayne Grody4, Allison M Cushman-Vokoun5, William K Funkhouser6, Scott E Kopetz7, Christopher Lieu8, Noralane M Lindor9, Bruce D Minsky10, Federico A Monzon11, Daniel J Sargent12, Veena M Singh13, Joseph Willis14, Jennifer Clark15, Carol Colasacco16, R Bryan Rumble17, Robyn Temple-Smolkin18, Christina B Ventura16, Jan A Nowak19.   

Abstract

Entities:  

Year:  2017        PMID： 28165529      PMCID： PMC7263311          DOI： 10.1093/ajcp/aqw209

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  140 in total

1.  Comparative genomic analysis of primary versus metastatic colorectal carcinomas.

Authors:  Efsevia Vakiani; Manickam Janakiraman; Ronglai Shen; Rileen Sinha; Zhaoshi Zeng; Jinru Shia; Andrea Cercek; Nancy Kemeny; Michael D'Angelica; Agnes Viale; Adriana Heguy; Philip Paty; Timothy A Chan; Leonard B Saltz; Martin Weiser; David B Solit
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  EGFR antibodies in colorectal cancer: where do they belong?

Authors:  Axel Grothey
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

3.  KRAS genotyping as biomarker in colorectal cancer: a comparison of three commercial kits on histologic material.

Authors:  Aldo Cavallini; Anna Maria Valentini; Catia Lippolis; Daniela Campanella; Vito Guerra; Maria Lucia Caruso
Journal:  Anticancer Res       Date:  2010-12       Impact factor: 2.480

4.  Standard mutation nomenclature in molecular diagnostics: practical and educational challenges.

Authors:  Shuji Ogino; Margaret L Gulley; Johan T den Dunnen; Robert B Wilson
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

5.  Cetuximab and panitumumab in KRAS wild-type colorectal cancer: a meta-analysis.

Authors:  Fausto Petrelli; Karen Borgonovo; Mary Cabiddu; Mara Ghilardi; Sandro Barni
Journal:  Int J Colorectal Dis       Date:  2011-02-01       Impact factor: 2.571

6.  The Catalogue of Somatic Mutations in Cancer (COSMIC).

Authors:  S A Forbes; G Bhamra; S Bamford; E Dawson; C Kok; J Clements; A Menzies; J W Teague; P A Futreal; M R Stratton
Journal:  Curr Protoc Hum Genet       Date:  2008-04

Review 7.  Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.

Authors:  James J Biagi; Michael J Raphael; William J Mackillop; Weidong Kong; Will D King; Christopher M Booth
Journal:  JAMA       Date:  2011-06-08       Impact factor: 56.272

8.  Differences in the frequencies of K-ras c12-13 genotypes by gender and pathologic phenotypes in colorectal tumors measured using the allele discrimination method.

Authors:  Lihui Chow; Peng-Chan Lin; Jeffrey S Chang; Pei-Yi Chu; Pao-Kung Lee; Shan-Na Chen; Ying-Min Cheng; Jenq-Chang Lee; Jang-Yang Chang; Tsang-Wu Liu
Journal:  Environ Mol Mutagen       Date:  2011-08-25       Impact factor: 3.216

9.  Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapy.

Authors:  P Cejas; M López-Gómez; C Aguayo; R Madero; J Moreno-Rubio; J de Castro Carpeño; C Belda-Iniesta; J Barriuso; V Moreno García; E Díaz; E Burgos; M Gonzalez-Barón; J Feliu
Journal:  Curr Cancer Drug Targets       Date:  2012-02       Impact factor: 3.428

10.  Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.

Authors:  Enric Domingo; David N Church; Oliver Sieber; Rajarajan Ramamoorthy; Yoko Yanagisawa; Elaine Johnstone; Brian Davidson; David J Kerr; Ian P M Tomlinson; Rachel Midgley
Journal:  J Clin Oncol       Date:  2013-09-23       Impact factor: 44.544
View more
  7 in total

1.  Prognostic Impact of Total Lesion Glycolysis (TLG) from Preoperative 18F-FDG PET/CT in Stage II/III Colorectal Adenocarcinoma: Extending the Value of PET/CT for Resectable Disease.

Authors:  Sea-Won Lee; Hye Lim Park; Nara Yoon; Ji Hoon Kim; Jin Kyoung Oh; Jae Ho Buyn; Eun Kyoung Choi; Ji Hyung Hong
Journal:  Cancers (Basel)       Date:  2022-01-24       Impact factor: 6.639

2.  Resource Oriented Decision Making for Treatment of Metastatic Colorectal Cancer (mCRC) in a Lower-Middle Income Country: Egyptian Foundation of Medical Sciences (EFMS) Consensus Recommendations 2020.

Authors:  Noha Rashad; Mohamed Abdulla; Mohamed Farouk; Yasser Elkerm; Salem Eid Salem; Maha Yahia; Amr S Saad; Ahmed Hassan Abdel Aziz; Ghada Refaat; Ibrahim Awad; Maha ElNaggar; Khaled Kamal; Basel Refky; Mohamed Abdelkhalek; Ahmed Touny; Loay Kassem; Emad Shash; Abdelhay A Abdelhay; Bahaa Eldin Mahmoud; Karima Oualla; Nesrine Chraiet; Hussein AwadElkarim H Maki; Yasser Abdel Kader
Journal:  Cancer Manag Res       Date:  2022-02-28       Impact factor: 3.989

3.  Synthesis and biological evaluation of an epidermal growth factor receptor-targeted peptide-conjugated phthalocyanine-based photosensitiser.

Authors:  Evelyn Y Xue; Roy C H Wong; Clarence T T Wong; Wing-Ping Fong; Dennis K P Ng
Journal:  RSC Adv       Date:  2019-07-02       Impact factor: 4.036

4.  Colorectal cancers with a residual adenoma component: Clinicopathologic features and KRAS mutation.

Authors:  Hyoun Wook Lee; Boram Song; Kyungneun Kim
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

5.  Proteomic Approach for Searching for Universal, Tissue-Specific, and Line-Specific Markers of Extracellular Vesicles in Lung and Colorectal Adenocarcinoma Cell Lines.

Authors:  Svetlana Novikova; Natalia Shushkova; Tatiana Farafonova; Olga Tikhonova; Roman Kamyshinsky; Victor Zgoda
Journal:  Int J Mol Sci       Date:  2020-09-09       Impact factor: 5.923

6.  xDEEP-MSI: Explainable Bias-Rejecting Microsatellite Instability Deep Learning System in Colorectal Cancer.

Authors:  Aurelia Bustos; Artemio Payá; Andrés Torrubia; Rodrigo Jover; Xavier Llor; Xavier Bessa; Antoni Castells; Ángel Carracedo; Cristina Alenda
Journal:  Biomolecules       Date:  2021-11-29

7.  Artificial Intelligence Can Cut Costs While Maintaining Accuracy in Colorectal Cancer Genotyping.

Authors:  Alec J Kacew; Garth W Strohbehn; Loren Saulsberry; Neda Laiteerapong; Nicole A Cipriani; Jakob N Kather; Alexander T Pearson
Journal:  Front Oncol       Date:  2021-06-08       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.